202 related articles for article (PubMed ID: 32639074)
1. Update on multi-gene panel testing and communication of genetic test results.
Reid S; Pal T
Breast J; 2020 Aug; 26(8):1513-1519. PubMed ID: 32639074
[TBL] [Abstract][Full Text] [Related]
2. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.
Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA
J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943
[TBL] [Abstract][Full Text] [Related]
3. An overview of genetic services delivery for hereditary breast cancer.
Reid S; Spalluto LB; Lang K; Weidner A; Pal T
Breast Cancer Res Treat; 2022 Feb; 191(3):491-500. PubMed ID: 35079980
[TBL] [Abstract][Full Text] [Related]
4. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
6. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Piccinin C; Panchal S; Watkins N; Kim RH
Expert Rev Anticancer Ther; 2019 Sep; 19(9):787-801. PubMed ID: 31469018
[No Abstract] [Full Text] [Related]
7. Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.
Pederson HJ; Noss R
Semin Oncol; 2020 Aug; 47(4):182-186. PubMed ID: 32513422
[TBL] [Abstract][Full Text] [Related]
8. Multigene Panel Testing for Hereditary Cancer and Genetic Counseling.
Lee ES; Kim J; Han W
Adv Exp Med Biol; 2021; 1187():455-471. PubMed ID: 33983594
[TBL] [Abstract][Full Text] [Related]
9. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
10. Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice.
Doherty J; Bonadies DC; Matloff ET
J Genet Couns; 2015 Aug; 24(4):683-7. PubMed ID: 25475920
[TBL] [Abstract][Full Text] [Related]
11. Genetic tests to identify risk for breast cancer.
Lynch JA; Venne V; Berse B
Semin Oncol Nurs; 2015 May; 31(2):100-7. PubMed ID: 25951739
[TBL] [Abstract][Full Text] [Related]
12. Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.
Shin HC; Lee HB; Yoo TK; Lee ES; Kim RN; Park B; Yoon KA; Park C; Lee ES; Moon HG; Noh DY; Kong SY; Han W
Cancer Res Treat; 2020 Jul; 52(3):697-713. PubMed ID: 32019277
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
[TBL] [Abstract][Full Text] [Related]
15. Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.
Pal T; Vadaparampil ST
Cancer Control; 2012 Oct; 19(4):255-66. PubMed ID: 23037493
[TBL] [Abstract][Full Text] [Related]
16. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
[TBL] [Abstract][Full Text] [Related]
18. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
19. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk assessment for breast and gynecological malignancies.
Profato JL; Arun BK
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):1-5. PubMed ID: 25502427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
